MARKET

LUCD

LUCD

Lucid Diagnostics Inc.
NASDAQ
0.4163
+0.0349
+9.15%
Closed 19:57 11/12 EST
OPEN
0.4000
PREV CLOSE
0.3814
HIGH
0.4300
LOW
0.3826
VOLUME
2.36M
TURNOVER
--
52 WEEK HIGH
1.629
52 WEEK LOW
0.3030
MARKET CAP
84.61M
P/E (TTM)
-0.8876
1D
5D
1M
3M
1Y
5Y
1D
Lucid Diagnostics Reports Third Quarter 2026 Financial Results
NASDAQ · 2h ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 11h ago
Lucid Diagnostics (LUCD) Q3 2026 Earnings Call Transcript
The Motley Fool · 16h ago
Lucid Diagnostics Reports Third-Quarter Results and Medicare Progress
TipRanks · 18h ago
Lucid Diagnostics Inc. (LUCD) Reports Q3 Loss, Lags Revenue Estimates
NASDAQ · 19h ago
*Lucid Diagnostics 3Q EBITDA Loss $6.5M >LUCD
Dow Jones · 19h ago
*Lucid Diagnostics 3Q Rev $1.2M >LUCD
Dow Jones · 19h ago
*Lucid Diagnostics 3Q Loss/Shr 3c >LUCD
Dow Jones · 19h ago
More
About LUCD
Lucid Diagnostics Inc. is a commercial-stage cancer prevention medical diagnostics company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma (EAC). The Company's products include EsoGuard and EsoCheck. EsoGuard is a bisulfite-converted next generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells in office procedures. It consists of a vitamin pill-sized rigid plastic capsule tethered to a thin silicone catheter from which a soft silicone balloon with textured ridges emerges to swab surface esophageal cells. The Company is a subsidiary of PAVmed Inc.

Webull offers Lucid Diagnostics Inc stock information, including NASDAQ: LUCD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUCD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LUCD stock methods without spending real money on the virtual paper trading platform.